SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is surging after announcing a 20-year, $9.1 billion data center lease with Anthropic, marking a significant strategic pivot toward AI infrastructure. While bullish investors see this as a transformation into a high-margin data center play, the stock is experiencing intense intraday volatility as the community debates whether the massive contract justifies the price action or if it is merely a catalyst for profit-taking and potential future dilution.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic pivot toward AI infrastructure following its acquisition of Northern Data, a move that has significantly expanded its GPU capacity and data center footprint. The community is actively debating the potential for a massive short squeeze due to record-high short interest, while simultaneously analyzing the upcoming earnings report and formal guidance as key catalysts for a long-term re-rating.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is seeing heightened volatility and a sharp sell-off as investors react to a marginal revenue miss and revised growth expectations, overshadowing the company's strong profitability and share repurchase activity. While some community members are liquidating positions in fear of further downside, others are viewing the pullback as a prime 'loading zone' for a long-term recovery, citing robust fundamentals and an attractive forward valuation.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is trending as investors react to a significant leadership transition, with co-founders stepping in as co-CEOs to drive the next phase of growth following recent executive changes. The community is actively debating the company's long-term competitive position against industry incumbents, with many highlighting strong international growth and product innovation while balancing concerns over premium valuation and sector-wide pressures.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is trending as investors react to a combination of defense-sector momentum and the company's strategic pivot into AI infrastructure through its optical interconnect technology. The community is actively discussing rumors of high-profile partnerships and significant pending contract awards, driving speculation about the stock's potential for substantial growth.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock remains a primary focus for the community as investors weigh the impact of recent analyst downgrades against hopes for a long-term turnaround strategy in China. While many are frustrated by the stock's persistent downtrend and recent volatility, a vocal base of investors is using the current price levels to average down, betting on the strength of the brand and potential dividend-driven value.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to strong earnings results, a surge in backlog, and a massive 1GW steam turbine contract with Siemens Energy aimed at fueling AI data center power demand. The community is actively debating the company's long-term potential as a critical infrastructure play, with many bullish on its growth pipeline while others weigh the risks of high short interest and institutional price volatility.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

Quantum Corp (QMCO) is trending as retail investors debate the stock's future amid a significant price rally, ongoing concerns over its financial stability, and confusion regarding its exposure to the quantum computing sector. Community sentiment is deeply polarized, with bulls highlighting the stock's potential for momentum-driven short squeezes and AI-related storage demand, while bears point to heavy debt, earnings volatility, and potential regulatory scrutiny.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as investors brace for a critical earnings report, with the community actively debating whether the company can convert its massive $60B+ order backlog into sustainable profit margins. While bears point to governance concerns and legal overhangs, bulls are betting that strong execution and infrastructure demand will force a significant repricing of the stock.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors gear up for the company's investor webinar on September 9th, where management is expected to reveal crucial details regarding the Phase 3 trial design and commercial strategy for its once-weekly injectable levothyroxine candidate, XP-8121. The community remains highly focused on the potential of XP-8121 to become a multibillion-dollar blockbuster, while also closely tracking the rapid revenue growth of its cortisol-lowering medication, RECORLEV.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Legend Biotech is seeing significant investor attention following a breakout in preliminary quarterly sales for its flagship CAR-T therapy, which underscores the company's strong growth trajectory and progress toward long-term profitability. The community is actively discussing the stock's potential as a buyout candidate, as strong fundamentals and a robust clinical pipeline continue to drive bullish sentiment despite recent volatility.

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus...

LEGN Stock Plunges 15% After Sudden CEO Exit — But Analyst Reiterates Optimism In Company’s Under-Development Lymphoma Asset 

Equity

Legend said on Monday that Ying Huang stepped down as chief executive officer and board member effective July 24. 


Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress...

Why Is Legend Biotech Stock Falling Thursday?

Legend Biotech (LEGN) shares drop in premarket trading after pricing a $226M public offering. Get the latest technical levels here.read more...

Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.35 each, shares down 9% in pre-market trading.read more...

These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results

Legend Biotech (LEGN) reported Q1 losses of 3 cents per share and sales of $305.1 million, missing estimates. Stock rose 1.3% to $28.63. Analysts maintained ratings and adjusted price targets.read...

Legend Biotech Q1 Earnings Call Highlights

Legend Biotech Q1 Earnings Call Highlights...

Legend Biotech (LEGN) Projected to Post Earnings on Tuesday

Legend Biotech (NASDAQ:LEGN) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Zurcher Kantonalbank Zurich Cantonalbank Decreases Stake in Legend Biotech Corporation Sponsored ADR $LEGN

Zurcher Kantonalbank Zurich Cantonalbank lowered its stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 89.4% in the fourth quarter, according to the company in its most...

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen research firms that are currently covering the...

$LEGN Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.18 up 126.47% YoY
• Reported revenue of $387.5M up 51.93% YoY

Stocktwits

Legend Biotech

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.18 up 126.47% YoY
• Reported revenue of $387.5M up 51.93% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$21.72
Prev Close	$20.66
Open	$21.61
Dividend Yield	0.00%
50-Day Moving Average	$26.87
Beta	0.54
Avg. Volume	2.54M
PE Ratio	-15.19

52-Week High	$38.35
52-Week Low	$16.24
Market Capitalization	$3.84B
EPS (Annual)	-$1.61
Price to Book	3.97
Revenue Per Employee	$355,731.44

Feed

News

Sentiment

Earnings

Fundamentals

Info